Expression of human papillomavirus type 16 (HPV-16) major (L1) and minor (L2) capsid proteins in insect cells as polyhistidine fusion proteins.

نویسندگان

  • J Cason
  • P K Kambo
  • C Manse
  • R J Jewers
  • J M Best
چکیده

Thus to obtain HPV-16 L1 and L2 proteins for serological studies, we have produced fusion proteins with cleavable polyhistidine tails to permit purification on nickel affinity columns. HPV-16 L1 and L2 open readin frames (from HPV-16 isolate 112 [l]? were cloned into the Nco-1 sites of pAcSGHis (C) and pAcSGHis (A) vectors which were transfected into Sf-21 cells with wild type AcMNPV. The resulting (unpurified) HPV-16tl and L2 fusion proteins proteins respectively had major roducts of 61 and 67 KDa in western blots ?Figure 1). Figure 1. A: Left, Coomassie blue stained PAGE gel of molecular weight markers (M), uninfected Sf-21 cells (U), cells expressing non-fused (L1) or polyhistidine/Ll fusion protein (Llh). Right, corresponding western blot.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Human Papillomavirus Type16- L1 VLP Production in Insect Cells

  Objective(s):  Infection by high-risk papillomavirus is regarded as the major risk factor in the development of cervical cancer. Recombinant DNA technology allows expression of the L1 major capsid protein of HPV in different expression systems, which has intrinsic capacity to self-assemble into viral-like particles (VLP). VLPS are non-infectious, highly immunogenic and can elicit neutralizing...

متن کامل

Human papillomavirus genotype 16 pseudovirus production and purification in HEK-293FT cells

Introduction: Human papillomavirus (HPV) is the main causative agent of cervical cancer worldwide leading to a big health problem, especially in the developing countries. Among 14 common high-risk genotypes, HPV16 accounts for more than 50% of all cervical cancers. The current prophylactic vaccines against HPV infection are based on L1 protein. Due to some drawbacks in the current vaccines such...

متن کامل

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines

BACKGROUND Vaccination with minor capsid protein L2 induces antibodies that cross-neutralize diverse papillomavirus types. However, neutralizing antibody titers against the papillomavirus type from which the L2 vaccine was derived are generally higher than the titers against heterologous types, which could limit effectiveness against heterologous types. We hypothesized that vaccination with con...

متن کامل

Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes.

Expression of the structural proteins L1 and L2 of the human papillomaviruses (HPV) is tightly regulated. As a consequence, attempts to express these prime-candidate genes for prophylactic vaccination against papillomavirus-associated diseases in mammalian cells by means of simple DNA transfections result in insufficient production of the viral antigens. Similarly, in vivo DNA vaccination using...

متن کامل

Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence.

Encapsidation of papillomavirus DNA involves DNA-protein and protein-protein interactions. We sought to define the role of each human papillomavirus (HPV) capsid protein in HPV DNA encapsidation. HPV16 major (L1) and minor (L2) capsid proteins purified from recombinant vaccinia virus-infected cells were compared for their ability to bind nucleic acids. L2 protein, but not L1 protein, could bind...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Biochemical Society transactions

دوره 22 3  شماره 

صفحات  -

تاریخ انتشار 1994